You are here: Industry Insights > CMO

News List

Achillion appoints new CMO biospectrumasia
August 22, 2018
Achillion also expanded its clinical development group with the recent appointments of Laura Barrow, Pharm.D. as VP, Clinical Operations and Head of Project Management, and Marc Uknis, M.D. as VP of Clinical Development, Head of Nephrology Therapeutics.
Allegro Ophthalmics, prepping for phase 3, promotes CMO to CEO fiercebiotech
August 22, 2018
Allegro is busy working to see its eye disease candidate risuteganib into the final stages of testing, and will now have a new chief to help it through phase 3 and, it hopes, beyond.
Applied DNA reaches new milestones biospectrumasia
August 03, 2018
In the past 12 months, Applied DNA has shipped over 8,000 milligrams of PCR-produced linear DNA for use in Diagnostic and Therapeutic applications.
FDA approves Calcitriol’s new contract manufacturing submission biospectrumasia
July 18, 2018
This approval was necessary in order to market and commercialize Calcitriol in the United States.
Recipharm Acquires Sanofi’s UK CMO Biz contractpharma
June 19, 2018
Recipharm has acquired Sanofi’s manufacturing center and business in Holmes Chapel, UK, expanding its inhalation capabilities in the growing respiratory drug market with commercial drug product manufacturing.
Ex-Takeda executive takes up CMO post at CD47 biotech Trillium fiercebiotech
June 11, 2018
Trillium Therapeutics has named Yaping Shou, M.D., Ph.D., as its CMO. Shou joins the anti-CD7 cancer biotech from Takeda’s oncology department, where she worked as executive medical director.
Galecto Biotech Appoints CMO contractpharma
May 22, 2018
Galecto Biotech AB announced the appointment of Richard Marshall, MD, PhD, as chief medical officer.
Novartis appoints John Tsai as Head GDD, CMO biospectrumasia
April 23, 2018
At Novartis, he will be responsible for advancing the company's industry-leading pipeline of innovative medicines and biosimilars.
Novartis cancer chief joins biotech startup as CMO biospectrumasia
March 01, 2018
Peng was the global head of oncology translational medicine at Shanghai CNIBR (China Novartis Institutes for BioMedical Research).
Buying Excipients and APIs Could be Done Better Emil W. Ciurczak, Doramaxx Consulting
December 25, 2017
I have spent years dealing with the transfer of methods throughout a greatly extended supply chain.

Previous page 1 2 3 4 5 6 Next page